Provasculon
Cambridge
About Provasculon
Provasculon was founded to exploit the discovery by Richard Lee, MD, a cardiologist at Brigham and Women's Hospital and Associate Professor at Harvard Medical School, and Vincent Segers, MD, a researcher at Brigham and Women's Hospital, of novel forms of the growth factor Stromal Cell-Derived Factor-1 (SDF-1).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.2M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Nov 2011)
- Website: provasculon.com
- Phone: 617-914-0763
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/provasculon-971127 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.